<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31280190</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1791-7549</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jul-Aug</Season>
            </PubDate>
          </JournalIssue>
          <Title>In vivo (Athens, Greece)</Title>
          <ISOAbbreviation>In Vivo</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer.</ArticleTitle>
        <Pagination>
          <StartPage>1027</StartPage>
          <EndPage>1037</EndPage>
          <MedlinePgn>1027-1037</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.21873/invivo.11571</ELocationID>
        <Abstract>
          <AbstractText>Circulating tumor cells (CTCs), detached from the primary tumor or metastases and shed in the patient's bloodstream, represent a relatively easily obtainable sample of the cancer tissue that can indicate the actual state of cancer, and their evaluation can be repeated many times during the course of treatment. As part of liquid biopsy, evaluation of CTCs provides a lot of clinically relevant information, which reflects the actual, real-time conditions of the disease. CTCs can be used in cancer diagnosis or screening, real-time long-term disease monitoring and even therapy guidance. Their analysis can include their number, morphology, and biological features by using immunocytochemistry and all "-omic" technologies. This review describes methods of CTC isolation and potential clinical utilization in lung cancer.</AbstractText>
          <CopyrightInformation>Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maly</LastName>
            <ForeName>Vilem</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Genetics, Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Krajska Zdravotni a.s. Hospital, Usti nad Labem, Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maly</LastName>
            <ForeName>Ondrej</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Genetics, Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kolostova</LastName>
            <ForeName>Katarina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Genetics, Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bobek</LastName>
            <ForeName>Vladimir</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Genetics, Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic vbobek@centrum.cz.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Krajska Zdravotni a.s. Hospital, Usti nad Labem, Czech Republic.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Lower Silesian Oncology Centre, Wroclaw, Poland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3rd Department of Surgery, University Hospital FN Motol and 1st Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>In Vivo</MedlineTA>
        <NlmUniqueID>8806809</NlmUniqueID>
        <ISSNLinking>0258-851X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055088" MajorTopicYN="N">Early Detection of Cancer</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073890" MajorTopicYN="N">Liquid Biopsy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D025202" MajorTopicYN="N">Molecular Diagnostic Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009360" MajorTopicYN="N">Neoplastic Cells, Circulating</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Circulating tumor cells</Keyword>
        <Keyword MajorTopicYN="N">biomarker</Keyword>
        <Keyword MajorTopicYN="N">culturing</Keyword>
        <Keyword MajorTopicYN="N">liquid biopsy</Keyword>
        <Keyword MajorTopicYN="N">lung cancer</Keyword>
        <Keyword MajorTopicYN="N">review</Keyword>
      </KeywordList>
      <CoiStatement>The Authors have no conflict of interest regarding this study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31280190</ArticleId>
        <ArticleId IdType="pmc">PMC6689346</ArticleId>
        <ArticleId IdType="doi">10.21873/invivo.11571</ArticleId>
        <ArticleId IdType="pii">33/4/1027</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. Lyon, France. International Agency for Research on Cancer. 2018  Available from: https://gco.iarc.fr/ today, accessed (3 February 2019).</Citation>
        </Reference>
        <Reference>
          <Citation>Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7(1):1–11.  PMID: 25398926. DOI: 10.15252/emmm. 201303698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4309663</ArticleId>
            <ArticleId IdType="pubmed">25398926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63(1):199–215.  PMID: 22053740. DOI: 10.1146/annurev-med-062310-094219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22053740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danila DC, Samoila A, Patel C, Schreiber N, Herkal A, Anand A, Bastos D, Heller G, Fleisher M, Scher HI. Clinical validity of detecting circulating tumor cells by AdnaTest assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients. Cancer J. 2016;22(5):315–320.  PMID: 27749322. DOI: 10.1097/ PPO.0000000 000000220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5108569</ArticleId>
            <ArticleId IdType="pubmed">27749322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertoldo F, Boccardo F, Bombardieri E, Evangelista L, Valdagni R. Bone metastases from prostate cancer: Biology, diagnosis and management. Springer International Publishing. 2017 DOI: 10.1007/978-3-319-42327-2.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Y, Zhang Y, Du Z, Wu M, Zhang G. Detection of micrometastases in lung cancer with magnetic nanoparticles and quantum dots. Int J Nanomedicine. 2012;7:2315–2324.  PMID: 22661888. DOI: 10.2147/IJN.S30593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3357978</ArticleId>
            <ArticleId IdType="pubmed">22661888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Correnti M, Raggi C. Stem-like plasticity and heterogeneity of circulating tumor cells: Current status and prospect challenges in liver cancer. Oncotarget. 2017;8(4):7094–7115.  PMID: 27738343. DOI: 10.18632/oncotarget.12569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5351693</ArticleId>
            <ArticleId IdType="pubmed">27738343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, Takahashi T, Murakami H, Nakamura Y, Tsuya A, Shukuya T, Ono A, Akamatsu H, Watanabe R, Ono S, Mori K, Kanbara H, Yamaguchi K, Tanaka T, Matsunaga T, Yamamoto N. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS One. 2013;8(6):e67466.  PMID: 23840710. DOI: 10.1371/ journal.pone.0067466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3696066</ArticleId>
            <ArticleId IdType="pubmed">23840710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowes LE, Goodale D, Xia Y, Postenka C, Piaseczny MM, Paczkowski F, Allan AL. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer. Oncotarget. 2016;7(46):76125–76139.  PMID: 27764810. DOI: 10.18632/oncotarget.12682.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5342801</ArticleId>
            <ArticleId IdType="pubmed">27764810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alix Panabieres C. Epispot assay: Detection of viable DTCs/ CTCs in solid tumor patients. Recent Results Cancer Res. 2012;195:69–76.  PMID: 22527495. DOI: 10.1007/978-3-642-28160-0_6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22527495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cote RJ, Datar RH. Circulating tumor cells. Springer New York. 2016 DOI: 10.1007/978-1-4939-3363-1.</Citation>
        </Reference>
        <Reference>
          <Citation>Janssen Diagnostics  LLC CELLSEARCH® Circulating Tumor Cell Kit (Epithelial) Instructions for Use.  Available at https://documents.cellsearchctc.com/pdf/e631600001/e631600001_EN.pdf. Last accessed on 7th May 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Raimondi C, Gradilone A, Naso G, Cortesi E, Gazzaniga P. Clinical utility of circulating tumor cell counting through cellsearch((r)): The dilemma of a concept suspended in limbo. Onco Targets Ther. 2014;7:619–625.  PMID: 24790460. DOI: 10.2147/OTT.S46200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4000244</ArticleId>
            <ArticleId IdType="pubmed">24790460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med . 2004;351(8):781–791.  PMID: 15317891. DOI: 10.1056/NEJMoa040766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15317891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302–6309.  PMID: 18829513. DOI: 10.1158/1078-0432.CCR-08-0872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18829513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009;20(7):1223–1229.  PMID: 19282466. DOI: 10.1093/annonc/mdn786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19282466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>QUIAGEN CTCs and AdnaTest flyer.  Available at: https://www.qiagen.com/us/resources/download.aspx?id=eedcab71-d26d-4414-96d7-cf8206db23bd&amp;lang=en.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Y, Navin NE. Advances and applications of single-cell sequencing technologies. Mol Cell. 2015;58(4):598–609.  PMID: 26000845. DOI: 10.1016/j.molcel.2015.05.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4441954</ArticleId>
            <ArticleId IdType="pubmed">26000845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miltenyi Biotec MACS® Cell Separation.  Available at: https://www.miltenyibiotec.com/_Resources/Persistent/b5349effdd595b72195e588aff033be3e24706bd/IM0020021.pdf. Last accessed on 7th May 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Fluxion Biosciences IsoFlux™ System.  Available at: https://www.accela.eu/files/products/44/isoflux-brochure.pdf. Last accessed on 7th May 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007;450(7173):1235–1239.  PMID: 18097410. DOI: 10.1038/nature06385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3090667</ArticleId>
            <ArticleId IdType="pubmed">18097410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP, Jr. Jr., Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA, Toner M. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA. 2010;107(43):18392–18397.  PMID: 20930119. DOI: 10.1073/pnas.1012539107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2972993</ArticleId>
            <ArticleId IdType="pubmed">20930119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harouaka RA, Nisic M, Zheng SY. Circulating tumor cell enrichment based on physical properties. J Lab Autom. 2013;18(6):455–468.  PMID: 23832928. DOI: 10.1177/2211068 213494391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3830628</ArticleId>
            <ArticleId IdType="pubmed">23832928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laget S, Broncy L, Hormigos K, Dhingra DM, BenMohamed F, Capiod T, Osteras M, Farinelli L, Jackson S, Paterlini Brechot P. Technical insights into highly sensitive isolation and molecular characterization of fixed and live circulating tumor cells for early detection of tumor invasion. PLoS One. 2017;12(1):e0169427.  PMID: 28060956. DOI: 10.1371/journal. pone.0169427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5218415</ArticleId>
            <ArticleId IdType="pubmed">28060956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolostova K, Cegan M, Bobek V. Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture. Can Urol Assoc J. 2014;8(9-10):E715–E720.  PMID: 25408812. DOI: 10.5489/cuaj.1978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4216304</ArticleId>
            <ArticleId IdType="pubmed">25408812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hvichia GE, Parveen Z, Wagner C, Janning M, Quidde J, Stein A, Muller V, Loges S, Neves RP, Stoecklein NH, Wikman H, Riethdorf S, Pantel K, Gorges TM. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells. Int J Cancer. 2016;138(12):2894–2904.  PMID: 26789903. DOI: 10.1002/ijc.30007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5069649</ArticleId>
            <ArticleId IdType="pubmed">26789903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirozzi G, Tirino V, Camerlingo R, La Rocca A, Martucci N, Scognamiglio G, Franco R, Cantile M, Normanno N, Rocco G. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncol Rep. 2013;29(5):1763–1768.  PMID: 23426441. DOI: 10.3892/or.2013.2294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23426441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Chen K, Fan ZH. Circulating tumor cell isolation and analysis. Adv Clin Chem. 2016;75:1–31.  PMID: 27346614. DOI: 10.1016/bs.acc.2016.03.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5123699</ArticleId>
            <ArticleId IdType="pubmed">27346614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greiner Bio-One OncoQuick® Instruction Manual.   Available at: https://www.gbo.com/fileadmin/user_upload/999999_UserGuide_OncoQuick_E.pdf. Last accessed on 7th May 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Lu J, Fan T, Zhao Q, Zeng W, Zaslavsky E, Chen JJ, Frohman MA, Golightly MG, Madajewicz S, Chen WT. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer. 2010;126(3):669–683.  PMID: 19662651. DOI: 10.1002/ijc.24814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2795034</ArticleId>
            <ArticleId IdType="pubmed">19662651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, Yu M, Chen PI, Morgan B, Trautwein J, Kimura A, Sengupta S, Stott SL, Karabacak NM, Barber TA, Walsh JR, Smith K, Spuhler PS, Sullivan JP, Lee RJ, Ting DT, Luo X, Shaw AT, Bardia A, Sequist LV, Louis DN, Maheswaran S, Kapur R, Haber DA, Toner M. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med. 2013;5(179):179ra147–179ra147.  PMID: 23552373. DOI: 10.1126/scitranslmed.3005616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3760275</ArticleId>
            <ArticleId IdType="pubmed">23552373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devriese LA, Bosma AJ, van de Heuvel MM, Heemsbergen W, Voest EE, Schellens JH. Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker qpcr analysis. Lung Cancer. 2012;75(2):242–247.  PMID: 21820198. DOI: 10.1016/j.lungcan.2011.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21820198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Marquette CH, Poudenx M, Sibon S, Kelhef S, Venissac N, Jais JP, Mouroux J, Molina TJ, Vielh P, Hofman P. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (iset) method. Cytopathology. 2012;23(1):30–38.  PMID: 21210876. DOI: 10.1111/j.1365-2303.2010.00835.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21210876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G, Ranson M, Dive C, Blackhall FH. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011;29(12):1556–1563.  PMID: 21422424. DOI: 10.1200/JCO.2010.28.7045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21422424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Xiao Y, Zhao J, Chen M, Xu Y, Zhong W, Xing J, Wang M. Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer. Respirology. 2016;21(3):519–525.  PMID: 26661896. DOI: 10.1111/resp.12696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26661896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coco S, Alama A, Vanni I, Fontana V, Genova C, Dal Bello MG, Truini A, Rijavec E, Biello F, Sini C, Burrafato G, Maggioni C, Barletta G, Grossi F. Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy. Int J Mol Sci. 2017;18(5) PMID: 28492516. DOI: 10.3390/ijms18051035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5454947</ArticleId>
            <ArticleId IdType="pubmed">28492516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapeleris J, Kulasinghe A, Warkiani ME, Vela I, Kenny L, O’Byrne K, Punyadeera C. The prognostic role of circulating tumor cells (ctcs) in lung cancer. Front Oncol. 2018;8:311.  PMID: 30155443. DOI: 10.3389/fonc.2018.00311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6102369</ArticleId>
            <ArticleId IdType="pubmed">30155443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosbie PA, Shah R, Krysiak P, Zhou C, Morris K, Tugwood J, Booton R, Blackhall F, Dive C. Circulating tumor cells detected in the tumor-draining pulmonary vein are associated with disease recurrence after surgical resection of nsclc. J Thorac Oncol. 2016;11(10):1793–1797.  PMID: 27468936. DOI: 10.1016/j.jtho.2016.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5063509</ArticleId>
            <ArticleId IdType="pubmed">27468936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BG, Hicks RJ, Hampton GM, Amler LC, Pirzkall A, Lackner MR. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res. 2012;18(8):2391–2401.  PMID: 22492982. DOI: 10.1158/1078-0432.CCR-11-3148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22492982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Poudenx M, Sibon S, Kelhef S, Venissac N, Jais JP, Mouroux J, Molina TJ, Hofman P. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res. 2011;17(4):827–835.  PMID: 21098695. DOI: 10.1158/1078-0432.CCR-10-0445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21098695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielcikova Z, Jakabova A, Pinkas M, Zemanova M, Kolostova K, Bobek V. Circulating tumor cells: What we know, what do we want to know about them and are they ready to be used in clinics. Am J Transl Res. 2017;9(6):2807–2823.  PMID: 28670371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5489883</ArticleId>
            <ArticleId IdType="pubmed">28670371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong B, Xu Y, Zhao J, Chen M, Xing J, Zhong W, Wang M. Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy. Oncotarget. 2017;8(49):86615–86624.  PMID: 29156821. DOI: 10.18632/ oncotarget.21255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5689711</ArticleId>
            <ArticleId IdType="pubmed">29156821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Del Ben F, Turetta M, Celetti G, Piruska A, Bulfoni M, Cesselli D, Huck WT, Scoles G. A method for detecting circulating tumor cells based on the measurement of single-cell metabolism in droplet-based microfluidics. Angew Chem Int Ed Engl. 2016;55(30):8581–8584.  PMID: 27247024. DOI: 10.1002/anie. 201602328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27247024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turetta M, Bulfoni M, Brisotto G, Fasola G, Zanello A, Biscontin E, Mariuzzi L, Steffan A, Di Loreto C, Cesselli D, Del Ben F. Assessment of the mutational status of nsclc using hypermetabolic circulating tumor cells. Cancers (Basel) 2018;10(8) PMID: 30110953. DOI: 10.3390/cancers10080270 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6115779</ArticleId>
            <ArticleId IdType="pubmed">30110953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ilie M, Szafer Glusman E, Hofman V, Long Mira E, Suttmann R, Darbonne W, Butori C, Lalvee S, Fayada J, Selva E, Yu W, Marquette CH, Shames DS, Punnoose E, Hofman P. Expression of met in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients. Oncotarget. 2017;8(16):26112–26121.  PMID: 28212 540. DOI: 10.18632/oncotarget.15345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5432243</ArticleId>
            <ArticleId IdType="pubmed">28212540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guibert N, Delaunay M, Lusque A, Boubekeur N, Rouquette I, Clermont E, Mourlanette J, Gouin S, Dormoy I, Favre G, Mazieres J, Pradines A. Pd-l1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab. Lung Cancer. 2018;120:108–112.  PMID: 29748004. DOI: 10.1016/j.lungcan.2018.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29748004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marchetti A, Del Grammastro M, Felicioni L, Malatesta S, Filice G, Centi I, De Pas T, Santoro A, Chella A, Brandes AA, Venturino P, Cuccurullo F, Crino L, Buttitta F. Assessment of egfr mutations in circulating tumor cell preparations from nsclc patients by next generation sequencing: Toward a real-time liquid biopsy for treatment. PLoS One. 2014;9(8):e103883.  PMID: 25137181. DOI: 10.1371/journal.pone.0103883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4138040</ArticleId>
            <ArticleId IdType="pubmed">25137181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Ramnath N, Nagrath S. Current status of ctcs as liquid biopsy in lung cancer and future directions. Front Oncol. 2015;5:209.  PMID: 26484313. DOI: 10.3389/fonc.2015.00209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4588111</ArticleId>
            <ArticleId IdType="pubmed">26484313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collisson EA, Campbell JD, Brooks AN, Berger, AH, Lee W, Chmielecki J, Beer DG. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–550.  PMID: 25079552. DOI: 10.1038/nature13385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neil HD, Wilkerson MD, Schultz N, Bose R, Chu A, Collisson EA, Cope L. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519–525.  PMID: 22960745. DOI: 10.1038/nature11404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3466113</ArticleId>
            <ArticleId IdType="pubmed">22960745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faugeroux V, Pailler E, Auger N, Taylor M, Farace F. Clinical utility of circulating tumor cells in alk-positive non-small-cell lung cancer. Front Oncol. 2014;4:281.  PMID: 2541 4829. DOI: 10.3389/fonc.2014.00281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4220657</ArticleId>
            <ArticleId IdType="pubmed">25414829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demeulemeester J, Kumar P, Moller EK, Nord S, Wedge DC, Peterson A, Mathiesen RR, Fjelldal R, Zamani Esteki M, Theunis K, Fernandez Gallardo E, Grundstad AJ, Borgen E, Baumbusch LO, Borresen Dale AL, White KP, Kristensen VN, Van Loo P, Voet T, Naume B. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Genome Biol. 2016;17(1):250.  PMID: 27931250. DOI: 10.1186/s13059-016-1109-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5146893</ArticleId>
            <ArticleId IdType="pubmed">27931250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diaz LA Jr., Bardelli A. Liquid biopsies: Genotyping circulating tumor DNA. J Clin Oncol. 2014;32(6):579–586.  PMID: 24449238. DOI: 10.1200/JCO.2012.45.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4820760</ArticleId>
            <ArticleId IdType="pubmed">24449238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolostova K, Spicka J, Matkowski R, Bobek V. Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. Am J Transl Res. 2015;7(7):1203–1213.  PMID: 26328005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4548313</ArticleId>
            <ArticleId IdType="pubmed">26328005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu SH, Tsai WS, Chang YH, Chou TY, Pang ST, Lin PH, Tsai CM, Chang YC. Identifying cancer origin using circulating tumor cells. Cancer Biol Ther. 2016;17(4):430–438.  PMID: 26828696. DOI: 10.1080/15384047.2016.1141839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4910938</ArticleId>
            <ArticleId IdType="pubmed">26828696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reis-Filho JS, Carrilho C, Valenti C, Leitao D, Ribeiro CA, Ribeiro SG, Schmitt FC. Is ttf1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas. Pathol Res Pract. 2000;196(12):835–840.  PMID: 11156325. DOI: 10.1016/S0344-0338(00)80084-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11156325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lianidou ES. Gene expression profiling and DNA methylation analyses of ctcs. Mol Oncol. 2016;10(3):431–442.  PMID: 26880168. DOI: 10.1016/j.molonc.2016.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5528973</ArticleId>
            <ArticleId IdType="pubmed">26880168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J, Arora KS, Desai N, Dahl DM, Sequist LV, Smith MR, Kapur R, Wu CL, Shioda T, Ramaswamy S, Ting DT, Toner M, Maheswaran S, Haber DA. Rna-seq of single prostate ctcs implicates noncanonical wnt signaling in antiandrogen resistance. Science. 2015;349(6254):1351–1356.  PMID: 26383955. DOI: 10.1126/ science.aab0917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4872391</ArticleId>
            <ArticleId IdType="pubmed">26383955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT, Aceto N, Bersani F, Brannigan BW, Xega K, Ciciliano JC, Zhu H, MacKenzie OC, Trautwein J, Arora KS, Shahid M, Ellis HL, Qu N, Bardeesy N, Rivera MN, Deshpande V, Ferrone CR, Kapur R, Ramaswamy S, Shioda T, Toner M, Maheswaran S, Haber DA. Single-cell rna sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep. 2014;8(6):1905–1918.  PMID: 25242334. DOI: 10.1016/j.celrep.2014.08.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4230325</ArticleId>
            <ArticleId IdType="pubmed">25242334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang M, Nelson R, Ros A. Toward analysis of proteins in single cells: A quantitative approach employing isobaric tags with maldi mass spectrometry realized with a microfluidic platform. Anal Chem. 2016;88(13):6672–6679.  PMID: 27257853. DOI: 10.1021/acs.analchem.5b03419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27257853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinkala E, Sollier-Christen  E, Renier C, Rosas-Canyelles E, Che J, Heirich K, Duncombe TA, Vlassakis J, Yamauchi KA, Huang H, Jeffrey SS, Herr AE. Profiling protein expression in circulating tumour cells using microfluidic western blotting. Nat Commun. 2017;8:14622.  PMID: 28332571. DOI: 10.1038/ ncomms14622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5376644</ArticleId>
            <ArticleId IdType="pubmed">28332571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabel L, Proudhon C, Gortais H, Loirat D, Coussy F, Pierga JY, Bidard FC. Circulating tumor cells: Clinical validity and utility. Int J Clin Oncol. 2017;22(3):421–430.  PMID: 28238187. DOI: 10.1007/s10147-017-1105-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28238187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897–6904.  PMID: 15501967. DOI: 10.1158/1078-0432.CCR-04-0378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15501967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantel K, Deneve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, Riethdorf S, Alix-Panabieres C. Circulating epithelial cells in patients with benign colon diseases. Clin Chem. 2012;58(5):936–940.  PMID: 22205690. DOI: 10.1373/clinchem. 2011.17 5570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22205690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bobek V, Kolostova K, Kucera E. Circulating endometrial cells in peripheral blood. Eur J Obstet Gynecol Reprod Biol. 2014;181:267–274.  PMID: 25195200. DOI: 10.1016/j.ejogrb. 2014.07.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25195200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuessel L, Kasimir-Bauer S, Zeillinger R, Pateisky P, Ott J, Zeisler H, Birdir C. Detection of circulating trophoblast particles in maternal blood using density gradient centrifugation in preeclampsia and in normotensive pregnancies. Hypertens Pregnancy. 2016;35(3):323–329.  PMID: 26930176. DOI: 10.3109/10641955.2016.1143487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26930176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castro J, Sanchez L, Nunez MT, Lu M, Castro T, Sharifi HR, Ericsson C. Screening circulating tumor cells as a noninvasive cancer test in 3388 individuals from high-risk groups (ICELLATE2) Dis Markers. 2018;2018:4653109.  PMID: 29997714. DOI: 10.1155/2018/4653109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5994570</ArticleId>
            <ArticleId IdType="pubmed">29997714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y, Shi J, Shi G, Xu X, Liu Q, Liu C, Gao Z, Bai J, Shan B. Using the new cellcollector to capture circulating tumor cells from blood in different groups of pulmonary disease: A cohort study. Sci Rep. 2017;7(1):9542.  PMID: 28842574. DOI: 10.1038/s41598-017-09284-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5572713</ArticleId>
            <ArticleId IdType="pubmed">28842574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud JM, Padovani B, Mouroux J, Marquette CH, Hofman P. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One. 2014;9(10):e111597.  PMID: 25360587. DOI: 10.1371/ journal.pone.0111597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4216113</ArticleId>
            <ArticleId IdType="pubmed">25360587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowe AC. Circulating tumor cells: Applications in cytopathology. Surg Pathol Clin. 2018;11(3):679–686.  PMID: 30190148. DOI: 10.1016/j.path.2018.04.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30190148</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
